Ikerian AG / RetinAI US Inc.
We enable the right decisions sooner in healthcare
RetinAI develops certified software solutions to enable the right decisions sooner in clinics and pharma, making institutions more efficient with insights and knowledge from data. Our software collects, organizes and analyzes health data from clinic level all the way to global scale pharma studies. Our 1st product, RetinAI Discovery, is redefining the industry standards, enabling improved management and oversight of clinical studies and real time monitoring and analysis of data, increasing the process efficiency and paving the way for distribution of personalized digital precision medicine.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
02.05.2025
RetinAI and FVS co-developed solution obtains CE-MDR Certification (startupticker.ch)
16.10.2024
USD 8M and a strategic partner for Ikerian AG (startupticker.ch)
16.10.2024
Ikerian Secures USD 8 Million in Series B funding to expand RetinAI discovery across Europe (venturelab.swiss)
03.07.2024
Ikerian secures EU MDR Certificate for multiple assets (startupticker.ch)
02.05.2024
Ikerian raises USD 6.18M in Series A Extension Financing round (startupticker.ch)
Last Tweets
No Jobs
No videos and documents
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders China
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Ikerian AG / RetinAI US Inc.
We enable the right decisions sooner in healthcare
Website:
retinai.com
Headquarter:
Bern
Foundation Date:
December 2016
Technology:
- Medtech
Sectors:
- Big Data
- Cloud
- Digital Health
- Hightech
- Diagnostics
- Machine Learning / AI
- Imaging and Radiology
- Medtech
- SaaS
- Software
Support received
